Treatment of latent tuberculosis: Rational and regimens

被引：0
|
作者：
Fraisse, P. [1 ]
机构：
[1] Hop Univ Strasbourg, Grp TB, Serv Pneumol, Soc Pneumol Longue Francaise, F-67091 Strasbourg, France
来源：
JOURNAL DES ANTI-INFECTIEUX | 2011年 / 13卷 / 03期
关键词：
Antitubercular agents; Isoniazid; Rifampin; Tuberculosis; Latent tuberculosis infection; ISONIAZID PREVENTIVE THERAPY; PULMONARY TUBERCULOSIS; INFECTION; RIFAMPIN; PROPHYLAXIS; CHILDREN; RISK; PYRAZINAMIDE; HEPATOTOXICITY; CONTACT;
D O I：
10.1016/j.antinf.2011.07.002
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Treatment of latent tuberculosis infection is a key component of tuberculosis control programs. We describe here the benefit to risk ratio of this therapy at the individual and collective levels. Acceptance and adherence influence the efficiency of this treatment. A close follow-up of the patients is necessary to avoid toxicity. Isoniazid monotherapy for 6 to 9 months or isoniazid plus rifampin for 3 months are the most commonly used regimens. French guidelines are presented. (C) 2011 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码：191 / 200
页数：10
相关论文
共 50 条
  • [1] New short regimens for latent tuberculosis treatment: safety first!
    Menzies, Dick
    Trajman, Anete
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2018, 52 (06)
  • [2] Costs and Cost-effectiveness of Four Treatment Regimens for Latent Tuberculosis Infection
    Holland, David P.
    Sanders, Gillian D.
    Hamilton, Carol D.
    Stout, Jason E.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 179 (11) : 1055 - 1060
  • [3] Tolerability of rifapentine-based regimens in latent tuberculosis infection treatment in the elderly
    Chan, Pei-Chun
    Lee, Pin-Hui
    Lu, Min-Ju
    Huang, You-Chieh
    Feng, Teng-Yi
    Chen, Wen-Wen
    Lee, Chia-Chi
    Huang, Yen-Fang
    Chiang, Chen-Yuan
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2019, 53 (03)
  • [4] Systematic review of shorter 2-3 months regimens for treatment of latent tuberculosis
    Acuna-Villaorduna, Carlos
    Lau-Deza, July
    Mora, Jorge
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2013, 42
  • [5] Directly observed treatment of latent tuberculosis infection:: comparative study of two isoniazid regimens
    Portilla, J
    Jordá, P
    Esteban, J
    Sánchez-Payá, J
    Merino, E
    Boix, V
    [J]. ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA, 2003, 21 (06): : 293 - 295
  • [6] Latent tuberculosis infection treatment completion in Biscay: differences between regimens and monitoring approaches
    Laza, N. Ortiz
    Aranaga, I. Lopez
    Andres, J. Toral
    Uriarte, B. Toja
    Zorrozua, B. Santos
    Urrengoechea, L. Altube
    Garay, J. Garros
    Huguet, E. Tabernero
    [J]. FRONTIERS IN MEDICINE, 2023, 10
  • [7] Novel Regimens Identified in Mice for Treatment of Latent Tuberculosis Infection in Contacts of Patients with Multidrug-Resistant Tuberculosis
    Lanoix, Jean-Philippe
    Betoudji, Fabrice
    Nuermberger, Eric
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2014, 58 (04) : 2316 - 2321
  • [8] Latent tuberculosis treatment
    Houston, S
    Long, R
    Hoeppner, V
    [J]. CANADIAN MEDICAL ASSOCIATION JOURNAL, 2002, 167 (05) : 452 - 453
  • [9] Tuberculosis treatment:: dangerous regimens?
    Rieder, HL
    Arnadottir, T
    Trébucq, A
    Enarson, DA
    [J]. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2001, 5 (01) : 1 - 3
  • [10] DOSING REGIMENS IN THE TREATMENT OF TUBERCULOSIS
    BLOMBULOW, B
    [J]. SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 1991, : 258 - 261
12345